{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T07:53:01Z","timestamp":1789804381949,"version":"4.0.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,25]],"date-time":"2020-05-25T00:00:00Z","timestamp":1590364800000},"content-version":"am","delay-in-days":359,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.revmed.2018.10.389","type":"journal-article","created":{"date-parts":[[2018,11,11]],"date-time":"2018-11-11T17:07:30Z","timestamp":1541956050000},"page":"389-394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["La crise des overdoses am\u00e9ricaines\u00a0: une menace pour la France\u00a0?"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8196-5511","authenticated-orcid":false,"given":"D.","family":"Vodovar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Langrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0755-2030","authenticated-orcid":false,"given":"N.","family":"Tournier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"M\u00e9garbane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2018.10.389_bib0540","series-title":"Annual report of the International Narcotics Control Board for 2015","author":"International Narcotic Control Board","year":"2016"},{"key":"10.1016\/j.revmed.2018.10.389_bib0280","series-title":"Understanding the epidemic","author":"Center for Disease Control Prevention","year":"2018"},{"key":"10.1016\/j.revmed.2018.10.389_bib0285","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1111\/bcp.13564","article-title":"Trends in analgesic consumption in France over the last 10\u00a0years and comparison of patterns across Europe","volume":"84","author":"Hider-Mlynarz","year":"2018","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.revmed.2018.10.389_bib0290","article-title":"Prescription opioid analgesic use in France: trends and impact on morbidity-mortality","author":"Chenaf","year":"2018","journal-title":"Eur J Pain"},{"key":"10.1016\/j.revmed.2018.10.389_bib0295","series-title":"Pharmacology and physiology for anesthesia e-book: foundations and clinical application","author":"Hemmings","year":"2013"},{"key":"10.1016\/j.revmed.2018.10.389_bib0300","doi-asserted-by":"crossref","first-page":"5391","DOI":"10.1073\/pnas.90.12.5391","article-title":"A brief history of opiates, opioid peptides, and opioid receptors","volume":"90","author":"Brownstein","year":"1993","journal-title":"Pnas"},{"key":"10.1016\/j.revmed.2018.10.389_bib0305","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1146\/annurev-med-062613-093100","article-title":"Opioid Receptors","volume":"67","author":"Stein","year":"2016","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.revmed.2018.10.389_bib0310","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.15585\/mmwr.mm655051e1","article-title":"Increases in drug and opioid-involved overdose deaths \u2013 United States, 2010\u20132015","volume":"65","author":"Rudd","year":"2016","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.revmed.2018.10.389_bib0315","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1146\/annurev-pharmtox-010617-052534","article-title":"The opioid epidemic: crisis and solutions","volume":"58","author":"Skolnick","year":"2018","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.revmed.2018.10.389_bib0320","unstructured":"National Institute on Drug Abuse. Overdose death rates, 2018. https:\/\/www.drugabuse.gov\/related-topics\/trends-statistics\/overdose-death-rates. Acc\u00e8s au site le 01\/10\/2018"},{"key":"10.1016\/j.revmed.2018.10.389_bib0325","unstructured":"Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: results from the 2016\u00a0National Survey on drug use and health, 2017. https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/NSDUHFFR1-2016\/NSDUH-FFR1-2016.htm. Acc\u00e8s au site le 01\/10\/2018"},{"key":"10.1016\/j.revmed.2018.10.389_bib0330","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1526-4637.2011.01075.x","article-title":"Societal costs of prescription opioid abuse, dependence, and misuse in the United States","volume":"12","author":"Birnbaum","year":"2011","journal-title":"Pain Med"},{"key":"10.1016\/j.revmed.2018.10.389_bib0335","doi-asserted-by":"crossref","first-page":"k3096","DOI":"10.1136\/bmj.k3096","article-title":"Changes in midlife death rates across racial and ethnic groups in the United States: systematic analysis of vital statistics","volume":"362","author":"Woolf","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.revmed.2018.10.389_bib0340","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/MLR.0000000000000625","article-title":"The economic burden of prescription opioid overdose, abuse, and dependence in the United States","volume":"54","author":"Florence","year":"2016","journal-title":"Med Care"},{"key":"10.1016\/j.revmed.2018.10.389_bib0345","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJM198001103020221","article-title":"Addiction rare in patients treated with narcotics","volume":"302","author":"Porter","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2018.10.389_bib0350","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1056\/NEJMc1700150","article-title":"A 1980\u00a0letter on the risk of opioid addiction","volume":"376","author":"Leung","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2018.10.389_bib0355","first-page":"31","article-title":"The rise of opiophobia: is history a barrier to prescribing?","volume":"20","author":"Rhodin","year":"2006","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"10.1016\/j.revmed.2018.10.389_bib0360","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1082-3174(96)80076-6","article-title":"APS 1995\u00a0Presidential address","volume":"5","author":"Campbell","year":"1996","journal-title":"Pain Forum"},{"key":"10.1016\/j.revmed.2018.10.389_bib0365","first-page":"514","article-title":"Is the WHO analgesic ladder still valid? Twenty-four years of experience","volume":"56","author":"Vargas-Schaffer","year":"2010","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.revmed.2018.10.389_bib0370","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2105\/AJPH.2007.131714","article-title":"The promotion and marketing of oxycontin: commercial triumph, public health tragedy","volume":"99","author":"Van Zee","year":"2009","journal-title":"Am J Public Health"},{"key":"10.1016\/j.revmed.2018.10.389_bib0375","series-title":"The family that built an empire of pain. The New Yorker","author":"Keefe","year":"2017"},{"key":"10.1016\/j.revmed.2018.10.389_bib0545","series-title":"High-risk drug use and new psychoactive substances","author":"European Monitoring Center for Drugs and Addiction","year":"2017"},{"key":"10.1016\/j.revmed.2018.10.389_bib0385","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000337028","article-title":"Misuse of medicines in the European Union: a systematic review of the literature","volume":"18","author":"Casati","year":"2012","journal-title":"Eur Addict Res"},{"key":"10.1016\/j.revmed.2018.10.389_bib0390","unstructured":"European Monitoring Center for Drugs and Addiction. European Drug Report 2017: trends and developments, 2017. http:\/\/www.emcdda.europa.eu\/publications\/edr\/trendsdevelopments\/2017_en. Acc\u00e8s au site le 01\/10\/2018"},{"key":"10.1016\/j.revmed.2018.10.389_bib0395","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/187447370801150611184218","article-title":"The misuse of prescription opioids: a threat for Europe?","volume":"8","author":"van Amsterdam","year":"2015","journal-title":"Curr Drug Abuse Rev"},{"key":"10.1016\/j.revmed.2018.10.389_bib0400","doi-asserted-by":"crossref","first-page":"e76499","DOI":"10.1371\/journal.pone.0076499","article-title":"Misuse and dependence on non-prescription codeine analgesics or sedative H1\u00a0antihistamines by adults: a cross-sectional investigation in France","volume":"8","author":"Roussin","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.revmed.2018.10.389_bib0405","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.drugalcdep.2018.01.036","article-title":"Doctor shopping of opioid analgesics relative to benzodiazepines: a pharmacoepidemiological study among 11.7\u00a0million inhabitants in the French countries","volume":"187","author":"Pont\u00e9","year":"2018","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.revmed.2018.10.389_bib0410","unstructured":"Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament. D\u00e9c\u00e8s en relation avec l\u2019abus de m\u00e9dicaments et de substances: principaux r\u00e9sultats enqu\u00eate DRAMES 2016, 2018. https:\/\/ansm.sante.fr\/var\/ansm_site\/storage\/original\/application\/5dfc3b8f413db7130062b63ca842b298.pdf. Acc\u00e8s au site le 01\/10\/2018"},{"key":"10.1016\/j.revmed.2018.10.389_bib0415","unstructured":"Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament. D\u00e9c\u00e8s toxiques par antalgiques. R\u00e9sultats 2016, 2018. https:\/\/www.ansm.sante.fr\/var\/ansm_site\/storage\/original\/application\/e2c21b8483d38a07bd86771f0c770f4e.pdf. Acc\u00e8s au site le 01\/10\/2018"},{"key":"10.1016\/j.revmed.2018.10.389_bib0420","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1080\/15563650.2017.1388087","article-title":"2016\u00a0Annual report of the American association of poison control centers\u2019 national poison data system (NPDS): 34th Annual Report","volume":"55","author":"Gummin","year":"2017","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.revmed.2018.10.389_bib0425","unstructured":"World Health Organization. Tramadol IFPMA comments for the WHO expert committee on drug dependence, 2014. http:\/\/www.who.int\/medicines\/areas\/quality_safety\/TRAMADOL_IFPMA_Comments.pdf. Acc\u00e8s au site le 01\/10\/"},{"key":"10.1016\/j.revmed.2018.10.389_bib0550","series-title":"Understanding the synthetic drug market: the NPS factor","author":"United Nations Office on Drugs and Crime","year":"2018"},{"key":"10.1016\/j.revmed.2018.10.389_bib0435","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drugalcdep.2016.11.033","article-title":"A review: fentanyl and non-pharmaceutical fentanyls","volume":"171","author":"Suzuki","year":"2017","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.revmed.2018.10.389_bib0440","doi-asserted-by":"crossref","first-page":"349","DOI":"10.15585\/mmwr.mm6712a1","article-title":"Overdose deaths involving opioids, cocaine, and psychostimulants \u2014 United States, 2015\u20132016","volume":"67","author":"Seth","year":"2018","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.revmed.2018.10.389_bib0445","series-title":"Tramadol-related deaths - 2016\u00a0overview. European joint DRD expert meeting Lisbon","author":"Giraudon","year":"2016"},{"key":"10.1016\/j.revmed.2018.10.389_bib0450","series-title":"\u00c9tude r\u00e9trospective des intoxications aigu\u00ebs au tramadol 2007\u20132013\u00a0\u00e0 partir des donn\u00e9es du centre antipoison et de toxicovigilance de Bordeaux: impact du retrait du dextropropoxyph\u00e8ne [th\u00e8se]","author":"Cassier","year":"2014"},{"key":"10.1016\/j.revmed.2018.10.389_bib0455","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJMra1202561","article-title":"Management of opioid analgesic overdose","volume":"367","author":"Boyer","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2018.10.389_bib0460","first-page":"e1651","article-title":"Respiratory failure following organophosphate poisoning: a literature review","volume":"9","author":"Giyanwani","year":"2017","journal-title":"Cureus"},{"key":"10.1016\/j.revmed.2018.10.389_bib0465","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0196-0644(05)80933-3","article-title":"The empiric use of naloxone in patients with altered mental status: a reappraisal","volume":"20","author":"Hoffman","year":"1991","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.revmed.2018.10.389_bib0470","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1378\/chest.120.5.1628","article-title":"Heroin-related noncardiogenic pulmonary edema: a case series","volume":"120","author":"Sporer","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.revmed.2018.10.389_bib0475","doi-asserted-by":"crossref","first-page":"1382.e1","DOI":"10.1016\/j.amjmed.2018.04.025","article-title":"Tramadol: understanding the risk of serotonin syndrome and seizures","volume":"131","author":"Hassamal","year":"2018","journal-title":"Am J Med"},{"key":"10.1016\/j.revmed.2018.10.389_bib0480","first-page":"577","article-title":"A systematic review of the cardiotoxicity of methadone","volume":"14","author":"Alinejad","year":"2015","journal-title":"Excli J"},{"key":"10.1016\/j.revmed.2018.10.389_bib0485","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2165\/00139709-200625020-00002","article-title":"Does high-dose buprenorphine cause respiratory depression?: possible mechanisms and therapeutic consequences","volume":"25","author":"Megarbane","year":"2006","journal-title":"Toxicol Rev"},{"key":"10.1016\/j.revmed.2018.10.389_bib0490","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003088-198409010-00001","article-title":"First-pass elimination. Basic concepts and clinical consequences","volume":"9","author":"Pond","year":"1984","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.revmed.2018.10.389_bib0495","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/2042098617744161","article-title":"Naloxone dosage for opioid reversal: current evidence and clinical implications","volume":"9","author":"Rzasa Lynn","year":"2018","journal-title":"Ther Adv Drug Saf"},{"key":"10.1016\/j.revmed.2018.10.389_bib0500","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.reaurg.2006.06.016","article-title":"Les antidotes","volume":"15","author":"Hantson","year":"2006","journal-title":"Reanimation"},{"key":"10.1016\/j.revmed.2018.10.389_bib0505","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.drugalcdep.2012.07.004","article-title":"Polydrug abuse: a review of opioid and benzodiazepine combination use","volume":"125","author":"Jones","year":"2012","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.revmed.2018.10.389_bib0510","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jsat.2010.01.006","article-title":"Prospective comparative assessment of buprenorphine overdose with heroin and methadone: clinical characteristics and response to antidotal treatment","volume":"38","author":"M\u00e9garbane","year":"2010","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.revmed.2018.10.389_bib0515","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2165\/00003088-200746110-00004","article-title":"Mechanism-based pharmacokinetic-pharmacodynamic modelling of the reversal of buprenorphine-induced respiratory depression by naloxone: a study in healthy volunteer","volume":"46","author":"Yassen","year":"2007","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.revmed.2018.10.389_bib0520","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.taap.2016.09.013","article-title":"Mechanisms of tramadol-related neurotoxicity in the rat: does diazepam\/tramadol combination play a worsening role in overdose?","volume":"310","author":"Lagard","year":"2016","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.revmed.2018.10.389_bib0525","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1080\/15563650.2017.1401080","article-title":"Is naloxone the best antidote to reverse tramadol-induced neuro-respiratory toxicity in overdose? An experimental investigation in the rat","volume":"56","author":"Lagard","year":"2018","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.revmed.2018.10.389_bib0530","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/add.14033","article-title":"Pharmacokinetics of concentrated naloxone nasal spray for opioid overdose reversal: Phase I healthy volunteer study","volume":"113","author":"McDonald","year":"2017","journal-title":"Addiction"},{"key":"10.1016\/j.revmed.2018.10.389_bib0535","first-page":"631","article-title":"Centers for Disease Control and Prevention (CDC). Opioid overdose prevention programs providing naloxone to laypersons \u2013 United States, 2014","volume":"64","author":"Wheeler","year":"2015","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.revmed.2018.10.389_bib0270","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.revmed.2018.03.014","article-title":"Point sur la crise des opio\u00efdes","volume":"39","author":"Martinez","year":"2018","journal-title":"Rev Med Interne"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866318311640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866318311640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:40:40Z","timestamp":1759336840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866318311640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0248866318311640"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2018.10.389","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"La crise des overdoses am\u00e9ricaines\u00a0: une menace pour la France\u00a0?","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2018.10.389","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}